People With COVID-19 Being Asked To Join Clinical Trial Aimed At Easing Symptoms
People who get COVID-19 are being asked to take part in a new clinical trial. CardiAI Inc, a Calgary-based biotechnology company, has been given provincial regulatory approval to test a mix of medications that could help alleviate symptoms and stop the virus from getting worse. It consists of two different parts – people recovering from the virus in the hospital and those in quarantine at home or other secure areas. Dr. Anmol Kapoor, who’s overseeing the trial, tells Mix News many areas of COVID-19 continue to be unknown, including treatments. “We don’t know if the strategy may be hel...